Search results
Results from the WOW.Com Content Network
BARDA provided initial funding of $20 million but could provide up to $100 million over a period of 4–5 years. [ 40 ] In 2017, BARDA signed a three-year $8.1 million contract with InBios International, Inc. of Seattle, Washington to develop a “ point-of-care diagnostic test that may be able to determine within 15 minutes whether a patient ...
The funding from the award will be disbursed in two installments, with an initial sum of about $65.7 million accessible immediately to facilitate ongoing study start-up endeavors.
Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executed; Development work is based on ModeX proprietary MSTAR technology that incorporates multiple antibody binding sites into a single molecule
The new award follows a $483 million grant provided by BARDA in April, which means Moderna has now received a total of $955 million in funding from the U.S. government.The award coincides with the ...
The funding is part of a partnership with the Biomedical Advanced Research and Development Authority (BARDA). Under the multi-year contract CSL will deliver its MF59 adjuvant, an ingredient that ...
Significant funding goes to BARDA (Biomedical Advanced Research and Development Authority), part of DHHS. Funding for activities aimed at prevention has more than doubled since 2007 and is distributed among 11 federal agencies. [26] Efforts toward cooperative international action are part of the project.
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the Department of Health and Human Services. [1] Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that ...
The Biomedical Advanced Research and Development Authority (BARDA) has issued an $8.6 million contract to OraSure Technologies Inc (NASDAQ: OSUR) for developing a 2nd generation Ebola test on the ...